Rapid-access oncodermatology is associated with reduced corticosteroid use and supports continuation of anticancer therapy after treatment-related cutaneous toxicity [0.03%]
快速访问的肿瘤皮肤病学与皮质类固醇使用减少相关，并在与治疗相关的皮肤毒性后支持继续抗癌治疗
Yuyang Liu,Samuel X Tan,Nicholas M Muller et al.
Yuyang Liu et al.
Melanoma disparities in Utah: Disproportionate rates among Hispanic and non-White populations in a population-based analysis [0.03%]
犹他州的黑色素瘤差异：基于人口的分析中西班牙语裔和非白人人群发病率不成比例
David Hoyt,Austen Callister,Kimberly Herget et al.
David Hoyt et al.
Sensitivity of circulating tumor DNA in advanced mycosis fungoides: A retrospective case series [0.03%]
血清肿瘤DNA在进展期皮肤T细胞淋巴瘤中的敏感性：一起病例系列回顾研究
Jennifer DeSimone,Nidhi Kuchimanchi,Jafar Al-Mondhiry et al.
Jennifer DeSimone et al.
Socioeconomic status, disease duration, and DLQI scores in adults with moderate-to-severe atopic dermatitis: A multicenter cross-sectional study [0.03%]
一项关于中重度特应性皮炎成人患者的多中心横断面研究：经济社会地位、病程与DLQI评分之间的关系
Shrichand G Parasramani,Rickson Pereira,Anil Ganjoo et al.
Shrichand G Parasramani et al.
Anxiety and depression in patients with single versus multiple keloids: A cross-sectional study [0.03%]
单个与多个瘢痕疙瘩患者焦虑和抑郁状况的横断面研究
Lian Zhang,Yanyu Du,Dan Sun et al.
Lian Zhang et al.
Long-term follow-up of height and weight after propranolol treatment for infantile hemangiomas [0.03%]
普萘洛尔治疗婴幼儿血管瘤后对身高的长期随访研究
Jianning Sun,Ruixue Zhao,Ran Huo et al.
Jianning Sun et al.
Hormonal associations in frontal fibrosing alopecia: A systematic review [0.03%]
frontal fibrosing alopecia的激素关联：系统评价
Raymond Z Ezzat,Li-Chi Chen,Meshi Paz et al.
Raymond Z Ezzat et al.
Global burden of skin and subcutaneous disease across childhood and adolescence in 204 countries and territories, 1990-2021 [0.03%]
1990年至2021年全球204个国家和地区儿童及青少年皮肤和皮下组织疾病负担研究
Jiehua Wei,Zhiwei Wang,Yuxuan Chen et al.
Jiehua Wei et al.
Demystifying longitudinal melanonychia: Low-cost 3D-printed nail models for patient education [0.03%]
揭秘纵向甲色素带：用于患者教育的低成本3D打印指甲模型
Nuran C Golbasi,Zachary J K Neubauer,NatalieDeana Badillo et al.
Nuran C Golbasi et al.
Real-world efficacy of oral upadacitinib for vitiligo and factors associated with treatment response: A retrospective study [0.03%]
乌帕替尼治疗白癜风的现实世界疗效及影响治疗反应的因素：一项回顾性研究
Yuexi Liu,Xiaoyi Shi,Yukun Yuan et al.
Yuexi Liu et al.